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Abstract
Background: A text messaging service (short message service [SMS]) has the potential to target large groups of people with
long-term illnesses such as serious mental disorders, who may have difficulty with treatment adherence. Robust research on the
impact of mobile technology interventions for these patients remains scarce.
Objective: The main objective of our study was to investigate the impact of individually tailored short text messages on the
rate of psychiatric hospital readmissions, health care service use, and clinical outcomes. In addition, we analyzed treatment costs.
Methods: Between September 2011 and November 2012, we randomly assigned 1139 people to a tailored text message
intervention (n=569) or usual care (n=570). Participants received semiautomated text messages for up to 12 months or usual care.
The primary outcome, based on routinely collected health register data, was patient readmission into a psychiatric hospital during
a 12-month follow-up period. Secondary outcomes were related to other service use, coercion, medication, adverse events,
satisfaction, social functioning, quality of life, and economic factors (cost analysis).
Results: There was 98.24% (1119/1139) follow-up at 12 months. Tailored mobile telephone text messages did not reduce the
rate of hospital admissions (242/563, 43.0% of the SMS group vs 216/556, 38.8% of the control group; relative risk 1.11; 95%
CI 0.92-1.33; P=.28), time between hospitalizations (mean difference 7.0 days 95% CI –8.0 to 24.0; P=.37), time spent in a
psychiatric hospital during the year (mean difference 2.0 days 95% CI –2.0 to 7.0; P=.35), or other service outcomes. People who
received text messages were less disabled, based on Global Assessment Scale scores at the time of their readmission, than those
who did not receive text messages (odds ratio 0.68; 95% CI 0.47-0.97; P=.04). The costs of treatment were higher for people in
the SMS group than in the control group (mean €10,103 vs €9210, respectively, P<.001).
Conclusions: High-grade routinely collected data can provide clear outcomes for pragmatic randomized trials. SMS messaging
tailored with the input of each individual patient did not decrease the rate of psychiatric hospital visits after the 12 months of
follow-up. Although there may have been other, more subtle effects, the results of these were not evident in outcomes of agreed
importance to clinicians, policymakers, and patients and their families.
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Introduction
Mobile technology has the potential to promote patient
self-management, leading to better health behaviors, which, in
turn, improve clinical outcomes among people with chronic
illnesses. Short message service (SMS) text messaging on
mobile telephones could address some of the chronic disease
management needs. Text messaging reminders are simple,
efficient options that enable direct or indirect communication
between health services and patients in a time- and cost-efficient
manner [1]. The majority of mHealth studies have tested basic
mobile phone features, such as text messaging [2], but the
effectiveness of using text messaging for supporting treatment
adherence among people with serious mental disorders, such
as schizophrenia, is still not clear [3].
The use of mHealth apps is expanding in various areas of health
care [4], including mental health [5], and likewise, the evaluation
of such apps is increasing [1]. Nevertheless, clear evidence of
the value of mHealth apps in improving adherence, within of
the realm of chronic disease management, is still lacking [6].
With regard to people with schizophrenia, for whom adherence
is particularly an issue [7], the relevant up-to-date Cochrane
review found that information and communication technology
(ICT)-based prompts were not clearly beneficial: in 1
randomized controlled trial with 320 participants, the relative
risk of stopping medication within 6 months was 1.11 (95% CI
0.96-1.29; moderate-quality evidence) [8]. Despite this, the
number of mHealth apps promoting medication adherence has
increased, including apps specifically targeted at improving
mental health [9]. The potential harm that such technology can
cause for people with chronic mental illnesses must also be
considered [10], although very few studies have specifically
addressed this issue [11]. Some patients find text messaging
disturbing and discontinue reading the messages [12]. In theory,
this could increase the sense of isolation among such patients,
resulting in decreasing adherence [13]. The effects of SMS text
messaging on mental health and health service use also remain
incompletely explored. To provide precise results of the effects
of text messaging on clinically relevant outcomes, high-grade,
longer-term, and adequately powered studies are needed [14].
In this paper, we report the findings of a large pragmatic,
multicenter, parallel-group, 12-month randomized controlled
clinical trial investigating the impact of individually tailored
SMS text messages on the rate of psychiatric hospital
readmissions, health care service use, and clinical outcomes.
We hypothesized that patients in the intervention group receiving
SMS prompts would have fewer psychiatric hospital
readmissions during the 12-month follow-up period, less service
use, fewer coercive incidents, less medication use, fewer adverse
events, higher satisfaction, higher social functioning, a better
quality of life, and lower treatment costs, compared with those
who did not receive SMS prompts. Our assumption behind our
hypothesis was that if text message reminders lead to improved
adherence to treatment—for example, to better medication
intake, appointment keeping, or self-management—then we
would see fewer hospital readmissions or other adverse events.
Methods
Design and Study Setting
The Mobile.Net study was initiated by the Academy of Finland
to assess the effectiveness of SMS text messaging in
encouraging medication compliance and self-care for people
with serious mental illnesses. We assumed that when a patient
is willing to take their medication frequently as prescribed, the
positive results can be seen as a decreased need for health service
use. Good patient medication adherence reduces the rate of
relapse and hospital readmissions [15]. The rationale, design,
and methods have previously been described [16]. The trial was
undertaken at psychiatric hospitals in Finland. We approached
the managers of the hospitals, sent them written material about
the study, and allowed them up to 3 weeks to decide if they
wanted their hospital to participate. Of 30 possible hospital
organizations, 24 organizations (45 wards) decided to take part.
The trial was approved by the Ethics Committee of the Hospital
District of Southwest Finland (December 16, 2010; ETMK
109/180/2010).
Participants
Participants in the trial were adults (aged 18-65 years) at the
point of discharge from a psychiatric hospital ward, for whom
ongoing antipsychotic medication had been advised. Each
participant had a mobile phone, was able to use the Finnish
language, and gave written informed consent to participate. We
did not include a formal test of capacity, but rather, we relied
on the judgment of experienced health care professionals in
their routine assessment of patients’ understanding, retention,
assimilation, and communication of information as patients
were nearing the point of discharge. Formalized assessment of
patient cognition is not part of routine psychiatric care in
Finland. We excluded people who had a planned nonacute
treatment period in a hospital ward, as well as those who were
being treated in forensic psychiatric services. Participants gave
written informed consent to take part in the study, complying
with the Declaration of Helsinki, the World Health Organization
principles of good clinical practice, and national requirements.
Randomization and Masking
We used a central randomization service at the University of
Turku (the Department of Mathematics and Statistics). The
study was individually randomized, open label, stratified by
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hospital, with a variable (random) permuted block length of 4
patients per block, to ensure that trial groups at each hospital
were balanced. The allocation was computer generated by an
independent statistician outside of the study and masked to
participants. The investigators who enrolled participants could
not foresee assignment. In addition, the statisticians, the outcome
assessors of the survey data, the data analysts, and the National
Register holder—responsible for the Finnish routine data used
in this study—were kept blinded to allocation. However, after
randomization, due to the type of intervention, the allocation
group was unmasked to participants, the research nurses at each
hospital, and the health care staff on the wards. While the Data
Management Committee undertook ongoing safety surveillance,
investigators running preliminary analyses for the Committee
were masked to data until the database was released.
The high number of hospitals and study wards included in the
trial necessitated that recruitment be undertaken in 10 waves,
between September 2011 and November 2012. A research
assistant, completely independent of the trial team (masked for
allocation), inserted the allocation numbers into sealed
envelopes. Written allocations of assignment, sealed in entirely
opaque individual envelopes and marked with a study
identification number, were distributed to each study ward.
Research nurses on each study ward sequentially assigned the
sealed envelopes in a predetermined order to people who had
both fulfilled the inclusion criteria and given their written
informed consent during their discharge process.
Recruitment
We used standardized, face-to-face informed consent procedures
for patient recruitment during the inpatient stays, before a patient
was discharged from the ward. Nurses were asked to identify
potentially eligible patients from the medical records. These
patients were given a short, 1-page information leaflet about
the study, and then, at their time of discharge, patients were
provided with more detailed written information with an
invitation to participate. If willing, patients then attended
appointments with a research nurse (specifically trained for this
task) to discuss practical arrangements, check eligibility, and
complete a baseline assessment (age, sex, marital status,
vocational education, employment status, and number of
psychiatric treatment periods) and study registration. Before
consenting, participants were made aware that they were free
to withdraw without obligation at any time and that such an
action would not adversely affect any aspect of their care. We
did not envisage that the intervention would interfere with
routine outpatient care.
Interventions
Patients in the experimental group received semiautomated
1-way text messages for up to 12 months from the time of
recruitment. To increase acceptability of the prompts and engage
users, the fundamental content of the 85 text messages was
designed by both service users and health care professionals
[16], and then tailored with input from each individual patient
at the point of randomization. Patients in the intervention group
selected compulsory text messages regarding medication (eg,
“Take your medication, please,” “It is important to take your
medication as prescribed.”) and treatment appointments
(“Remember to book a follow-up appointment,” “Please go to
your follow-up appointment.”), as well as voluntary text
messages related to their free time and daily management (“Are
your clothes clean and tidy?”, “Be more gentle with yourself.”).
Text message examples are translations from the Finnish
language. The content of the text messages is described in
greater detail in Kauppi et al [17].
Messages were selected in cooperation with the research nurses
on each ward and were recorded in a text message booklet. Text
message selection was based on patients’ preferences: each
patient was able to select the exact messages he or she wanted
[17]. There was no specific or predefined schedule for the
messages. However, to make sure patients did not receive an
overwhelming amount of text messages, and to prevent patient
habituation to the text messages [18], we limited the total
amount of text messages to up to 12 messages in a month. The
patients were able to choose the amount (between 2 and 12 text
messages per month), time (any time, day or night) and day of
the week (from Monday to Sunday) of the selected messages
(see Kauppi et al [17]). The messages were not personalized in
any other way, to protect patient privacy. Patient names and
information related to illnesses or medication were not
mentioned in the messages. The text messages were not
interactive (they were 1-way messages), and therefore no
response was required from patients. If a patient sent a message
to the research group, we reviewed it and contacted staff
members responsible for that particular patient if needed.
Otherwise, the patient would receive a general response,
unrelated to their treatment. Text messages were sent to the
patients automatically via a specific digital text message
reminder system. Table 1 provides a detailed description of the
intervention [19,20].
Research nurses (n=129) who worked on the study wards had
2 days of training, which covered theoretical and practical issues
in randomization and intervention management, and two 1-day
training updates during the trial. Each research nurse recorded
the number of patients in each ward, the eligible participants,
the number of those who refused, and those who gave informed
consent. Every 2 weeks, Mobile.Net researchers from the
research center (in Turku, Finland) made quality control
assessment phone calls to each of the 45 wards to ensure that
eligible patients were assessed, baseline data collected, and
ethical requirements followed. These calls also monitored
whether staff had received any messages from patients or their
caregivers describing discomfort or harm caused by the text
messages and to identify any problems in randomization. In
addition, we visited the research wards at least twice during the
recruitment period: we held face-to-face meetings with the
research nurses and staff members to ensure high-quality data
collection, maintained interest, and an esprit de corps. Email
support for the study ward was also available during the months
of patient recruitment.
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Table 1. Description of the short message service (SMS) text messaging interventiona.
DescriptionCategories
Tailored, patient-led SMS intervention.Brief name
The intervention is based on self-determination theory [20], which explains human motivation. The theory assumes that de-
veloping a sense of autonomy, competence, and relatedness is critical to processes of internalization and integration, through
which an individual comes to self-regulate and maintain behaviors beneficial to health and well-being. Intrinsic forms of
motivation involve engaging in behaviors for their own sake (eg, for challenge and enjoyment), while extrinsic forms of
motivation involve doing an activity because it is instrumental in achieving a separate consequence. Environments that promote
autonomy and support confidence are likely to enhance compliance and health outcomes.
Rationale and theory
Materials (and their users) were a computer with access to the Internet at the hospital (research nurses); mobile phone with
a SIMb card to receive text messages (patients); a paper-format text message library, including a list of 85 text messages with
the contact information of the research nurse and researchers (research nurses, patients).
Materials
The patients selected their favorite text messages from a text message library. The research nurse input each person’s preferences
of text messages into an electronic semiautomated system.
Procedures
The semiautomated system was managed by nurses in psychiatric hospitals.Providers
Messages continued for 12 months or until participants no longer wanted to receive the messages. The messages did not include
any personal health-related content (eg, identification codes or names, diagnoses, medication, or name of health services).
Participants were advised to inform researchers or research nurses if their mobile number changed, if they felt at all uncom-
fortable because of the received text messages, or in case of any technical problems.
How?
Patients received SMS messages after being discharged from psychiatric hospital.Where?
The timing, frequency, and conditions under which SMS messages were to be stopped were decided by the participants. The
total number of messages received, free of charge to patients, was limited to a maximum of 12 per month or 4 per week (the
minimum was 2 per month related to medication).
When and how much?
Patients were able to stop or change the topic, frequency, or timing of any messages by sending an email, telephoning, text
messaging, or mailing researchers or staff members.
Tailoring and modifi-
cations
aModified from the template for intervention description and replication (TIDieR) checklist and guide, Hoffmann et al [19].
bSIM: subscriber identity module.
All patients allocated to standard care (control group) continued
with usual care after discharge from hospital at the discretion
of their psychiatric and nursing team. The health professionals
were able to use any resources at their disposal to offer
maximum care for patients based on the existing system in
Finland, which does not automatically include regular text
messages. We did not restrict the use of any technological
applications for these people.
Outcomes
Primary Outcome
The intervention in the experimental group involved a maximum
of 12 months of SMS text messaging. We collected all of the
data for the primary outcome from routine data collection by
the Finnish national Care Register for Health Care (HILMO;
formerly the Finnish Hospital Discharge Register) [21]. The
register includes individual clinical and administrative data of
all people treated in psychiatric hospitals in Finland. The
completeness and accuracy of this register have been found to
vary from “satisfactory” to “very good” [22]. To our knowledge,
and that of those administering the register, Mobile.Net is the
first trial to use these routinely collected data for outcomes for
a randomized trial. The use of the register as the main outcome
source was important, as the focus of the study was to illustrate
the use of information on health utilization for consideration by
the multiple stakeholders for whom these routine data are
collected—especially health providers [23].
The primary outcome was patient readmission to a psychiatric
hospital (ie, how many patients [n, %] in each study arm were
readmitted to a psychiatric hospital during the 12-month
follow-up). The other outcomes related to service use were (1)
time to next hospitalization (how many days a patient was out
of the psychiatric hospital after discharge [days]), (2) time in a
psychiatric hospital during the year (total number of days
admitted in a psychiatric hospital during the 12-month follow-up
period), and (3) healthy time (number of days during the
12-month follow-up period when the person was not admitted
in a psychiatric hospital [days]). Each participant was followed
up for 12 months after discharge.
Secondary Outcomes
Secondary outcome data (also taken from routinely collected
data in the national register) included type of admission (n, %),
involuntary treatment (number of periods of care), general
hospital treatment, length of involuntary psychiatric treatment
(days), length of general hospital stay (days), use of private care
(data not available), coercion used (yes, no), and type of coercive
incidence according to the Finnish Mental Health Act
(1116/1990; seclusion, limb restraint, forced injection, physical
restraint), medication use (yes, no), type of medication
(antipsychotic, antipsychotic and antidepressant), and adverse
events (any [yes], death according the Statistics of Finland
[yes]). We assessed other secondary outcomes, patient
satisfaction with care or intervention (Client Satisfaction
Questionnaire-8 [CSQ-8], self-rated) [24], and quality of life
(Quality of Life Enjoyment and Satisfaction Questionnaire
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[Q-LES-Q], self-rated) [25] with a structured survey
supplemented by a postal or telephone survey 12 months after
randomization. Patient disability was assessed by patient
functioning (Global Assessment Scale [GAS], 0-100, staff rated)
[26], also taken from routinely collected data in the national
register. Outcomes concerning patient engagement in the
intervention (fidelity) were assessed by whether or not a patient
made a “request to stop SMS” (intervention group only) or
“leave the study early” (for any reason), relayed by the patient
or clinical staff members and recorded by the investigators after
informed consent.
We analyzed treatment-emergent adverse events, defined as any
harm or adverse events occurring between randomization and
when the patient completed the study, reported by anyone
involved. Information was collected by emails, telephone calls,
text messages (staff, patients, or relatives), and visits or
face-to-face meetings with staff members and recorded using a
standardized instrument originally based on the clinical research
monitoring and good clinical practices network [27]. We
categorized harms as unexpected or expected, at different levels
(a severe adverse event or an adverse event) [28]. Severe adverse
events were life-threatening (an event during which the patient
was at risk of death) or fatal, required inpatient hospitalization,
prolonged hospitalization, or resulted in a major disability [28].
We further categorized the adverse events into medical or
psychiatric problems or substance use.
We also ascertained research nurses’ and patients’ perceptions
regarding possible harms in using SMS (“In your opinion, have
text messages caused any harm to you/to patients?”, yes, no).
We interviewed all research nurses by telephone and interviewed
patients (in the intervention group) by telephone or postal survey
[29]. We collected information on patient deaths from the
national health register (causes of death register) [30]. We also
surveyed patients’ feedback on the intervention [29].
Cost Analysis
We examined the costs of the SMS intervention by calculating
the unit costs of staff time used for the intervention and text
message cost for each patient during the 12-month trial. We
prospectively estimated staff time (45 minutes per patient and
an additional 15 minutes to upload the messages into the
system). We estimated mean salary and overhead costs for staff
members (€3300 average monthly costs, including additional
staff costs of 23.25%, about €21.21 per hour) as referred to in
locally and nationally agreed-upon unit costs by the Union of
Health and Social Care Professionals in Finland [31]. The costs
of the text messages were assessed based on the total number
of text messages sent to each patient during the 12 months (total
67,560); the cost of each text message to Finnish consumers in
2011 was approximately €0.0004 [32].
To assess the direct costs of patient care, we prospectively
collected the treatment costs per day in a psychiatric hospital.
The average treatment costs for nonspecialized care wards (€408
per day per patient) and specialized care wards (€692 per day
per patient) were based on the nationally agreed-upon service
costs by the Ministry of Social Affairs and Health in 2011 [33].
For indirect costs, the data were not available.
Statistical Analysis
Power
Our primary analysis was based on a comparison of two
estimates between study groups at the 12-month follow-up. We
identified no comparable studies to assist our calculations. To
show the difference in reducing readmissions to hospitals by at
least 5 percentage points (a relative risk of 0.92) with 80% power
at a 5% 2-sided significance level, we estimated that we would
need a total of 1511 participants in each of the 2 arms (Stata
v10; StataCorp LP). In 2009, based on HILMO, there were 8339
people with schizophrenia (International Classification of
Diseases, 10th Revision [ICD-10] block F20-29) admitted to
psychiatric hospitals who used antipsychotic medication. We
hoped to be able to achieve this sample size in Mobile.Net [16].
Funding limitations compelled us to have a window of 15
months for recruitment.
Analysis
We carried out the analyses using the SAS System for Windows
(version 9.4; SAS Institute). The primary analysis was
intention-to-treat. We did not impute missing outcome data
because only 2% of the data were missing for the primary
outcome. For the secondary outcomes, we did not impute the
data either, even though about half of the data were missing
(regarding quality of life and satisfaction). The reason was that
the data were collected at only 1 time point. We summarized
descriptive characteristics of patients by study group, and
estimated either mean (SD), median (interquartile range), or
numbers and proportions as appropriate. Descriptive statistics
were used to evaluate outcomes at the end point and differences
between groups. The primary and secondary outcomes were
involved in the calculation of relative risk (RR), odds ratio (OR),
and median differences (Hodges-Lehmann estimate) or mean
differences and their corresponding 95% confidence intervals.
We took dependency between periods of care, measured from
the same participant, into account using generalized estimating
equations. Variables with yes or no answers were analyzed with
a Poisson regression model, while for other dichotomous
variables, binary logistic regression was used. We compared
mean differences between groups using a 2-sample t test and
median differences using a Mann-Whitney U test. Using data
from the primary outcome alone, we investigated the effect of
the SMS messaging for subgroups of people with
schizophrenia-like illnesses in comparison with all other
diagnostic labels. We considered 2-sided P<.05 to be statistically
significant.
Governance and Role of the Funding Source
The funder approved the design of the study, but had no role in
the design, data collection and analyses, data interpretation,
content of the manuscript, or submission for publication. A total
of 4 interim reviews with the Management and Safety
Committee were organized at 12, 14, 19, and 27 months after
recruitment began. As expected, data were not available at those
times to test the primary outcome of the hypothesis, so the
Committee based their consideration of when to stop patient
recruitment on analyses of recruitment speed (the number of
patients recruited each day), patient allocation in each group,
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and refusal rates. The Management and Safety Committee
oversaw the study. The corresponding author had full access to
all data and was ultimately responsible for the decision to submit
the manuscript for publication. TV and KAK also had access
to raw data in the study.
The trial is registered with the ISRCTN registry (27704027;
Multimedia Appendix 1 [34].
Results
During the 15 months of recruitment (September 5, 2011 to
November 30, 2012) a total of 11,530 patients were admitted
onto the 45 wards. Of 4186 potentially eligible patients, 3417
(81.63%) were invited to participate. The other 769 people
became ineligible because either they moved to another ward
before discharge or, upon further investigation, it was unclear
if they had the capacity to consent and participate or refuse
participation in the study (Figure 1). Key characteristics differing
between eligible and noneligible participants were that eligible
participants were younger and a larger proportion were women
(P<.001) [35]. One ward closed during the study period, but
recruited participants continued in the trial in another ward
without disruption.
In total, 1139 patients were randomly assigned to either the
experimental group with text messages (n=569) or the control
group (n=570). We excluded 16 patients from the data because
of a randomization error or because they withdrew consent or
were not eligible. Of the remaining 1123 people, the follow-up
was conducted with 563 (563/569, 98.9%) participants in the
intervention group and 560 (560/570, 98.2%) allocated to
standard care. After further quality checks of register data, we
excluded 4 people because of coding errors that could not be
corrected; therefore, data for these patients were not available.
This left 1119 (1119/1139, 98.24%) people for analysis. For
the survey-based outcomes (satisfaction, quality of life),
however, the data were available for 268 patients in the
intervention group (268/563, 47.6%) and 262 in the usual care
group (262/560, 46.8%) (Figure 1).
Table 2 shows the main characteristics of patients at baseline
and at the 12-month follow-up in the intervention (n=569) and
control groups (n=570). An equal number of female and male
patients participated (mean age 38 years). About half were single
and most of the participants had a low level of education.
Participants’ mean age at the time of the first contact with mental
health services was 27 years. The largest diagnosis group was
F20-29 (421/1050, 40.10%, schizophrenia, schizotypal and
delusional disorders, ICD-10; Table 2).
Figure 1. Flow diagram of study participants. SMS: short message service.
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Table 2. Patient characteristics.
Usual care (n=570)SMSa (n=569)Characteristic
Age in years, mean (SD)
38.0 (12); n=56938.5 (13); n=569At trial entry
26.9 (11); n=56027.4 (12); n=562At first contact with services
278/570 (48.8)301/569 (52.9)Female sex, n (%)
Marital status, n (%)
309/569 (54.3)277/565 (49.0)Single
151/569 (26.5)154/565 (27.3)Married
99/569 (17.4)120/565 (21.2)Divorced
10/569 (1.8)14/565 (2.5)Widowed
Vocational education, n (%)
172/564 (30.5)177/561 (31.6)None
79/564 (14.0)89/561 (15.9)Vocational training courses
162/564 (28.7)161/561 (28.7)Primary vocational skill certificate
90/564 (16.0)80/561 (14.3)Secondary vocational skill certificate
61/564 (10.8)54/561 (9.6)University degree
Employment status, n (%)
99/561 (17.6)108/560 (19.3)Employed
277/561 (49.4)269/560 (48.0)Retired
12/561 (2.1)15/560 (2.7)Self-employed
68/561 (12.1)60/560 (10.7)Student
105/561 (18.7)108/560 (19.3)Job seeker
Number of psychiatric treatment periods, n (%)
12/387 (3.1)9/455 (2.0)1
375/387 (97.0)446/455 (98.0)≥2 treatment periods or more
Diagnosis (ICD-10b block), n (%)
2/520 (0.4)1/535 (0.2)Organic, including symptomatic, mental disorders (F00-F09)
29/520 (5.6)31/535 (5.8)Mental and behavioral disorders due to psychoactive substance use (F10-F19)
209/520 (40.2)212/535 (39.6)Schizophrenia, schizotypal and delusional disorders (F20-F29)
163/520 (31.3)161/535 (30.1)Mood [affective] disorders (F30-F39)
40/520 (7.7)48/535 (9.0)Neurotic, stress-related and somatoform disorders (F40-F49)
4/520 (0.8)1/535 (0.2)Behavioral syndromes associated with physiological disturbances and physical factors (F50-F59)
63/520 (12.1)71/535 (13.3)Disorders of adult personality and behavior (F60-F69)
6/520 (1.2)4/535 (0.7)Mental retardation (F70-F79)
2/520 (0.4)3/535 (0.6)Disorders of psychological development (F80-F89)
2/250 (0.4)1/535 (0.2)Behavioral and emotional disorders with onset usually occurring in childhood and adolescence (F90-
F98)
aSMS: short message service text message intervention group.
bICD-10: International Classification of Diseases, 10th Revision.
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Table 3. Primary and secondary outcome analysis.
P
value
Coefficient (95% CI)Usual care (n=556)SMSa (n=563)Outcomes
Primary outcome, n (%)
.28RRb 1.11 (0.92 to 1.33)216/556 (38.8)242/563 (43.0)Readmission to psychiatric hospital
Secondary outcomes
.37MdDd 7.0 (–8.0 to 24.0)104.5 (39.5-197.0);
n=216
110.0 (44.0-
14.0); n=242
Time to next hospitalization (days), median (IQRc)
.35MdD 2.0 (–2.0 to 7.0)24.0 (10.0-67.0);
n=216
30.0 (12.0-67.0);
n=242
Time in psychiatric hospital during the year (days), median (IQR)
.08MdD –4.0 (–10.0 to 1.0)338.0 (293.5=352);
n=216
330.5 (285.0-
350.0); n=242
Healthy time (days), median (IQR)
Type of admission (number of periods of care), n (%)
.59ORf 0.89 (0.57 to 1.38)77/396 (19.4)78/442 (17.6)M1e referral
1/396 (0.3)0/442 (0)Mental examination
0/396 (0)0/442 (0)Determination of treatment
.54OR 1.14 (0.74 to 1.77)318/396 (80.3)364/442 (82.4)Other
.33RR 0.85 (0.61 to 1.18)95/390 (24.4)91/439 (20.7)Involuntary treatment (number of periods of care), n (%)
N/AN/AgUse of private care
.13MdD 0.0 (0.0 to 0.0)0.0 (0.0-0.0);
n=556
0.0 (0.0-0.0);
n=563
Length of general hospital treatment (days), median (IQR)
.35MdD –2.0 (–13.0 to 2.0)23.0 (5.0-79.0);
n=67
18.0 (5.0-61.0);
n=76
Length of involuntary treatment (days), median (IQR)
Coercion, n (%)
.92RR 0.97 (0.52 to 1.78)25/396 (6.3)27/442 (6.1)Coercive incidence (number of periods of care)
Type of coercive incidence (number of periods of care)
.75RR 1.12 (0.57 to 2.20)25/396 (6.3)20/443 (4.5)Seclusion
.77RR 1.19 (0.37 to 3.80)9/396 (2.3)12/443 (2.7)Limb restraint
.63RR 1.79 (0.16 to 19.46)1/396 (0.3)2/443 (0.5)Forced injection
.65RR 1.34 (0.38 to 4.70)4/396 (1.0)6/443 (1.4)Physical restraint
Medication, by type, n (%)
.74RR 0.96 (0.74 to 1.23)117/216 (54.2)125/241 (51.9)Antipsychotic
.57RR 1.08 (0.84 to 1.39)109/216 (50.5)131/241 (54.4)Antipsychotic + antidepressant
Adverse event, n (%)
.34RR 1.97 (0.49 to 7.90)3/556 (0.5)6/563 (1.1)Anyh (yes)
.32RR 0.68 (0.31 to 1.46)16/556 (2.9)11/563 (2.0)Death (yes)
Satisfaction with care/intervention/trial
.12MDj –0.69 (–1.50 to 0.18)23.1 (5.0); n=26222.4 (5.0); n=268Satisfied with care (CSQ-8i [24]), mean (SD)
N/Al24/563 (4.3)Request to stop SMSk, n (%)
.91RR 0.99 (0.84 to 1.16)294/556 (52.9)295/563 (52.4)Left the study earlym, n (%)
Social functioning, n (%)
.04CORp 0.68 (0.47 to 0.97)Disabilityn (GASo [26])
71/394 (18.0)106/442 (24.0)46-100
189/394 (48.0)223/442 (50.5)31-45
134/394 (34.0)113/442 (25.6)1-30
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P
value
Coefficient (95% CI)Usual care (n=556)SMSa (n=563)Outcomes
0.80MD 0.00 (–0.03 to 0.03)0.59 (0.17); n=2620.59 (0.18);
n=268
Quality of life (Q-LES-Qq [25] end point/change), mean (SD)
Economic factors, mean/median (IQR)
<.001MdD 26.8 (26 to 27)9210/0 (0-6936);
n=556
10,103/28 (26-
9410); n=563
Direct treatment costsr (€) (all)
0.25MdD 845 (794 to 3132)23,707/10,200
(4284-31,774);
n=216
23,469/13,080
(5331-29,314);
n=242
Direct treatment costs (€) (readmitted patients)
N/AN/AIndirect cost (€)
aSMS: short message service text message intervention group.
bRR: relative risk (Poisson regression).
cIQR: interquartile range.
dMdD: median difference (Hodges-Lehmann estimate, Mann-Whitney U test).
eM1 referral: referral for observation.
fOR: odds ratio (logistic regression).
gN/A: not available.
hMonitored by study investigators.
iCSQ-8: Client Satisfaction Questionnaire-8.
jMD: mean difference (2-sample t test).
kContact with the research team.
lN/A: not applicable.
mDid not return survey questionnaire.
nData from health register.
oGAS: Global Assessment Scale.
pCOR: cumulative odds ratio (<1 indicates less disability in the SMS group).
qQ-LES-Q: Quality of Life Enjoyment and Satisfaction Questionnaire
rTreatment cost per patient (€1=US $ 1.13, September 2015).
Table 3 provides estimates of treatment effects on primary and
secondary outcomes. Contrary to the preliminary assumption,
tailored mobile telephone text messages did not reduce patients’
use of health services in a psychiatric hospital (ie, readmission
rate, the primary outcome). In total, there were 838 readmissions
in the data. On the participant level, 40.93% (458/1119) of
participants were readmitted to a psychiatric hospital during the
follow-up period (242/563, 43.0% of the SMS group vs 216/556,
38.8% of the control group, RR 1.11, 95% CI 0.92-1.33).
Receiving the text messages did not have any clear effect on
time spent in hospital, time between hospitalizations, or number
of days in the year that the person was thought to be well
(healthy days).
No differences in other secondary outcomes were detected.
Regarding the survey base outcome, patients’ satisfaction with
care (mean 22.4 for the intervention group vs 23.1 for the
control, P=.12) or quality of life (mean 0.59 vs 0.59, P=.80) did
not differ statistically between the groups, while the response
rates dropped to 47.6% (268/563) and 46.8% (262/560) in the
intervention and control groups, respectively. People who
received text messages were, however, less disabled (based on
GAS scores) at the time of their hospital readmission than were
those who did not receive text messages (OR 0.68, 95% CI
0.47–0.97).
We analyzed patient engagement with the SMS text message
intervention. In total, 35 of 1123 participants contacted
researchers before the end of the 12-month follow-up to report
any changes or wanting to leave the study early [35]. Patients’
behavior regarding their text message selection was measured
during the study [17]. In all, 5.9% (33/563) of the participants
wanted to change the topic, receiving time, or frequency of the
SMS text messages. The reasons for the changes included
erroneously entering a message into the semiautomated system,
being dissatisfied with the topic or timing of the messages, or
simply wanting to stop or choose a new message [17].
Altogether, 95.2% (536/563) of the participants in the
intervention group continued the SMS text message intervention
throughout the entire 12 months, and 4.8% (27/563) dropped
out of the intervention [35]: 3 participants dropped out before
the intervention started, and 24 dropped out during the
intervention period. Reasons for dropping out included (8/27)
disliking the 1-way nature of the messages, finding the messages
to be irritating, or no longer finding the messages to be beneficial
(a more detailed description is found in Kannisto et al [35] and
Kauppi et al [17]).
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Table 4. Adverse events reported during the trial.
Usual care (n=560)SMSa (n=563)Adverse events
Adverse events, n (%)
3 (0.5)6 (1.0)Any
1 (0.2)1 (0.2)Mild
01 (0.2)Moderateb
2 (0.4)4 (0.7)Severeb
00Expected, severe
Unexpected, severe
2 (0.4)3 (0.5)Life-threatening or fatalb
00Requiring or prolonging hospitalization
01 (0.2)Major disabilityb,c
00Expected, less severe
Unexpected, less severe
01 (0.2)Medical
1 (0.2)2 (0.4)Psychiatric (paranoid thoughts)
00Substance use
aSMS: short message service text message intervention group.
bNot consequence of study.
cPhysical injury, not linked to study.
We also calculated the incremental cost of patient treatment per
rehospitalization period. The cost of treatment was higher for
people in the SMS group than the cost for the control group
(mean €10,103 vs €9210, P<.001). When we calculated the cost
of treatment for those who were readmitted to hospital, the
statistically significant difference disappeared (mean €23,469
vs €23,707, P=.25).
We conducted a subgroup analysis for the primary outcome to
compare people with schizophrenia-like illnesses versus those
with other diagnoses. The analysis showed that people allocated
to the SMS group who did not have schizophrenia-like illnesses
had more psychiatric hospital days (median 26.5 vs 18.5,
P=.047) and fewer healthy days (median 336 vs 345, P=.02)
than patients in the control group during the 12 months. For the
subgroup made up only of people with schizophrenia-like
illnesses, we identified no clear differences.
During the 12-month follow-up, 9 adverse events were reported
to the research staff (0.80% of 1119 participants). A total of 3
patients had paranoid experiences focused on the mobile phones
(2 mild events reported by nurses and 1 moderate event reported
by the patient by telephone or text messages to the researcher
staff, involving 2 from the SMS group and 1 from the control
group). One person in the intervention group had serious
physical problems because of a stroke, and another participant
wanted to stop the study. A total of 5 deaths were reported to
the research staff (0.45%, 3 in the SMS group, with no
discernible link to the text messages) (Table 4).
At the end of the study, we surveyed people allocated to the
SMS group (n=403) to ask how they reacted to the intervention.
A total of 51 participants (51/403, 12.7%) said that the text
message intervention caused them harm. For example, some
felt the text messages came too early in the day, others were
irritated because of the interruption in work or leisure time, and
some complained that the memory of the mobile phone filled
up too quickly. More women than men perceived harm (35/223,
15.7% vs 16/178, 9.0%, P=.05). About three-quarters of the
participants (274/383, 72%) were satisfied with the text message
intervention. Two-thirds (247/385, 64%) were willing to receive
text message intervention in the future (for more details, see
Kannisto and colleagues [29]). In all, 13.8% (8/58) of the
research nurses surveyed thought that the messaging caused
some harm to patients by, for example, exacerbating paranoid
thoughts. More female than male nurses thought that the text
messages caused harm to patients (8/41, 19.5% vs 0/17, 0%,
P=.05).
Discussion
Principal Findings
This was a pragmatic, multicenter, parallel-group randomized
controlled trial, of, for this subspecialty, a large group of people
with serious mental illnesses [16]. Our main assumption was
that the SMS intervention, aimed at creating a higher awareness
of health and well-being of individual patients, could change
behavior patterns and subsequent service use. However, at the
12-month follow-up on patient service use, we did not find any
advantages for the patients who used text messaging over the
patients who received standard care. A Cochrane review [8]
also did not find evidence that prompts increased patient
adherence to treatment. The review found that ICT-based
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prompts were not clearly beneficial. There was weak evidence
within this review suggesting small positive effects of SMS use
on measures of the mental state, insight, and quality of life of
patients, but the clinical significance of these data remains
unclear. There have been few similar studies for this client group
and few overlapping with Mobile.Net, and relevant trials were
small with measure outcomes far upstream in the care flow.
Findings from Mobile.Net serve to increase uncertainty whether
SMS messaging, in this context, has any discernible effects.
Interpretation of the SMS Results
Contrary to the hopes of many that mHealth will solve problems
such as limited reach and access, high costs, and low
effectiveness in the delivery of health care and other conditions,
this does not seem to be the case.
We had hoped that text message reminders would lead to
improved adherence to treatment, which, in turn, would be seen
as better medication intake, appointment keeping, or
self-management and, downstream, result in fewer hospital
readmissions or other adverse events. We could have
overestimated the power of a simple, 1-way, tailored, minimally
intrusive, technical approach to change behavior. Of course,
such an intervention is not enough to solve complex problems
for people with serious mental health problems. but it might
have helped engagement in care. Perhaps a more personalized
2-way communication and personal support would work. We
had no way of tracking patient behavior between sending a text
message and the health utilization outcomes in routine data.
More research into each patient’s adherence level by, for
example, detailed analysis of their health behavior, meetings
with staff members, or medication intake, would deepen
understanding of the impact of text message reminders on patient
adherence and health utilization. Notwithstanding this, the
simple SMS messaging we used did not work for important
downstream outcomes of importance to health care providers.
We can also speculate about other reasons why the SMS
intervention did not have a discernible effect on the chosen
available outcomes. Although, in our study, patient engagement
was high and people selected large numbers of text messages,
we cannot be sure how many participants actually received,
noted, or followed the content of the text messages. People may
also have closed their telephone accounts or changed their
prepaid systems during the intervention [36], or simply stopped
reading the text messages at some point during the trial period
[13]. These reasons seem improbable, though, and if they applied
in this study, there would have most likely been some suggestion
of one or both possibilities in our closing survey.
The one minor finding favoring the SMS intervention suggested
that people allocated to the text messaging group had better
global functioning scores (the Global Assessment of
Functioning, collected as routine data) when readmitted to
psychiatric hospital care. This is consistent with low-grade
evidence from the Cochrane review, where there seemed to be
some indication that ICT-based prompts had small positive
effects on patient insight [8]. Our result could also have been a
chance finding, as people in need of psychiatric treatment may
not eagerly seek help out of fear of stigmatization [37], because
they believe that treatment would be unhelpful, or as a result of
poor insight [38]. Another study [39] found that around 75%
(95% CI 72%-76%) of patients discontinued their medication
within 18 months of follow-up. However, this should be studied
in more detail, as even significant findings can also happen by
chance.
In our study, the difference between groups in the lengths of
involuntary treatment periods and patients’ stays in a psychiatric
hospital were not statistically significant. Of all patients admitted
to psychiatric hospitals in Finland in 2013 (N=26,561), less than
two-thirds (29%) were involuntary admitted [40]. At the same
time, those admitted to Finnish psychiatric hospitals had a 2-
to 3-fold higher mortality rate than the general population in
Sweden and Denmark [41]. Further, the total number of care
days in specialized psychiatric care came to 1,262,253 (38,384
treatment periods), and the average number of care days for
patients with schizophrenia spectrum psychosis (F20-29) was
60 days in 2013. If the length of the stay for each hospitalized
patient could be decreased by 1 day with any effective and
less-expensive intervention, it would mean substantial savings
all the way up to the Finnish annual health budget, and it would
also affect the quality of life for individual patients. Therefore,
in the realm of health services, small changes can have big
impacts.
Strengths and Limitations
This study has several strengths. By using health registers as
the main source of outcomes, the trial caused minimal extra
burden for people with the illnesses and their nursing staff. The
use of standardized outcome data reduced the possibility of
response or dropout bias, and if there were such errors, it is
unlikely that they would differ between the randomization
groups. The participation rate of hospitals was high (24/30,
80%), and the participation rate for eligible patients was
acceptable (around one-third), given the study population; that
is, patients with serious mental illness being discharged from
hospital. Randomization was successful, based on the evidence
that patients in the intervention group and the usual care group
were comparable on various indicators. The intervention itself
was patient centered, in both its development (involving both
end users and providers) and its execution (patients could choose
the messages they were to receive). The duration of the
follow-up period was 12 months, and the proportion of missing
data gathered in the national health register was exceptionally
small. When we added in our own questionnaire, outside of
routine data, however, compliance with data acquisition did
decrease, although it was still reasonably high (530/1123,
47.20%), considering the target population of the study.
Mobile.Net allowed for the acquisition of high-grade data
involving a detailed data monitoring system, which gathered
information about different hospital wards using case notes,
monitoring sheets, and frequent telephone calls to staff members
throughout Finland, as well as the use of routine data from
HILMO [21].
On the other hand, this study has its limitations. First, we did
not achieve the target sample size: we estimated that we would
need a total of 1511 participants in each of the 2 arms, and in
this sense our study was powered as planned. With the achieved
sample size, an 8-percentage-point difference in readmissions
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to hospitals between groups could be detected with 80% power
at a 5% significance level. In this regard, our sample size is still
adequate for drawing reliable conclusions.
Second, even though the majority of participants did not report
negative effects, 12.7% (51/403) of participants in the SMS
group and 13.8% (8/58) of the nurses associated with the
intervention expressed beliefs that the text messages caused
some harm to some participants. More women than men
perceived possible harm in receiving SMS reminders [29]. We
may assume here that some participants’ negative perceptions
may indicate a lack of tailoring of specific messages, or raise
questions on the type of interaction or suitability of the
intervention as experienced by the participants. For example,
2-way communication could have given valuable opportunities
to the participants to communicate with their treatment team to
receive support when needed. Despite some negative perceptions
of text messages, about three-quarters of the participants were
satisfied with the SMS text message intervention [29]. Whether
our finding can be generalized to a wider population needs to
be examined further.
Third, regarding the patient-focused questionnaires and
outcomes, such as patient satisfaction with care and quality of
life, the low follow-up rate for patient self-assessed instruments
(530/1123, 47.20%), although in keeping with trials among this
patient group [42], may bias our study results for these particular
outcomes. Those participants who did not participate in
follow-up surveys may have been dissatisfied and therefore did
not answer the survey. There was also a significant statistical
difference between the participants who did not answer the
follow-up survey and those who did fill out the questionnaires.
Fourth, the condition of the patient may have had some effect
on their attrition. For example, those with the lowest capacity
level and, therefore, perhaps with the greatest need for
supervision of medication intake, could have been
self-excluding. However, we could not verify this, as we had
no formal test to assess capacity for patients who participated
or did not participate in the study. On the other hand, we
recruited patients to the study at the time of their discharge
process, and therefore we may assume that the patients’ capacity
to be discharged from the psychiatric hospital would have
already been assessed by the psychiatrists responsible for the
patients’ treatment.
Fifth, we hypothesized that, if patient medication adherence is
better after the SMS intervention, the number of readmissions
might be lower in the intervention group. We measured patient
adherence by service utilization rather than by counting pills
[43], or examining computerized prescription refill records [44]
or blood tests, which may limit the sensitivity of the
measurement. We decided to measure care utilization outcomes
because our focus was on these outcomes, which can offer
usable information for health service providers and societies
for their decision making [45] and practicality in evaluating
new technology [46], and, importantly, can help to avoid using
methods that are invasive and place a burden on patients. Despite
potential problems in using care utilization as an indication of
the impact of the intervention, these outcomes are used as
indicators in the data from “real practice,” for policy initiatives
[46], and as proxy outcomes for economics. There is also a lack
of studies addressing questions related to delivery of mental
health services in randomized trials [47]. Tracking patient
medication adherence would still have been highly informative
about why simple SMS text messages did not work on
downstream outcomes but, we suggest, greatly undermined the
finding by promoting attrition. Objective investigation would
have increased our certainty regarding adherence to medication,
but this would have greatly threatened the pragmatic nature of
the trial. A lack of close monitoring of the messages received
by individual patients could therefore have hindered the fidelity
of the study, and a lack of tracking of a similar type of
technology in a control group should be interpreted as a study
limitation. The specificity of the study may also be questioned
in regard to its design, intervention, or outcomes to ascertain
which of the multiple factors affected patient behavior. Each
aspect of this complex intervention could then have been
subsequently open to further evaluation. Perhaps the tailoring
was indeed helpful, but our timing offset any positive effect.
Each factor could now be tested in further trials.
Sixth, a simple semiautomated SMS text message is not at all
a simple intervention. It involves the act of messaging, the nature
of the message, and timing. Our study population was perhaps
one of the most challenging, and also vulnerable for new
interventions. At the same time, evidence for effective
interventions to guide practitioners is scant, despite high levels
of need and costs of care for this group of patients [48]. The
selection of our study population can be defended due to its
high impact on health services and costs globally [49]. We are
also aware of the challenges of this particular patient group,
who have capacity problems [50], are less experienced in using
health technology [51], and are less motivated to engage in their
treatment [52], which may further limit the use of the new
technological intervention. However, it is important to test all
options for care in this group, especially like the one in this
study, which could be implemented without evaluation. Had
such an intervention been successful, even a small improvement
may have had wide repercussions in the utilization of health
services.
Our results still indicate that it is feasible to provide an
intervention, scalable for a wide group of people, that can be
delivered by a simple technological solution. This type of
intervention may make it possible to expand care provision
without being limited by specific service hours, staff motivation,
or availability of professionally trained health care staff. On the
other hand, because this intervention did not result in absolute
benefits of the service use, and yet did include possible negative
effects of mHealth on patients with serious mental illness, we
are compelled to draw attention to the following point. Many
hopes and promises are being attached to mHealth, in that it
could solve problems in health care services, such as human
resources, limited access, high costs, and the difficulty of
satisfying individual needs. There is also a great deal of belief
and investment in mHealth technology in several service
systems, conditions, and environments. Perhaps semiautomated
prompting text messages, particularly, are not the answer for
patients with serious mental health problems; a better alternative
could be to allocate resources to investigating alternative
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mHealth solutions or other interventions to solve care utilization
problems. We need to know the limitations of technology use
for various user groups, and when to invest in exploring other
strategies. This study also demonstrates how using routinely
collected health data sets proved to be possible within
randomized trials for important outcomes of clinical and public
health value. This may well be possible elsewhere, and not only
confined to countries known for culturally acceptable
comprehensive data collection.
Lessons Learned
Here are 7 things we would do differently in the future. First,
the patient inclusion criteria should be even more inclusive to
ensure a very large sample size. Second, negative perceptions
related to SMS interventions should be more thoroughly
investigated, and such potential problems should be considered
in future intervention development for different mobile apps.
Third, the intervention would have to be modified in the future
to include 2-way communication and collaboration with staff
(although currently still problematic), and an increase of
supportive, visual, or voice-based elements could offer more
interesting, albeit expensive, additions to the simple approach
we tested. Fourth, other patient-focused measurements, such as
treatment adherence, internal motivation, or adverse events
could be included to help increase understanding of the effects,
if any, of SMS from the patients’ point of view. Fifth, an
assessment of capacity level needs to be included in a baseline
assessment, at least for a random sample of the total. This would
provide a means for investigating how capacity might affect
results. Sixth, a random sample of the total number of patients
could be followed up to help track behavior after the
intervention. For this subsample, bill accounting, follow-up
calls, responses to 2-way text messages, or nurse or physician
assessment of patient participation in treatment would be needed.
We suggest this on a random sample, as we feel that such
detailed data acquisition could threaten validity by causing
attrition. Seventh, to engage vulnerable patients or those living
with mental health issues, collaboration with user groups or
patient association should be more active, beyond just the
consultations or meetings we conducted in this study.
Conclusions
Undisclosed effects could potentially be further explored in
future studies. Perhaps the small suggestion that those in the
SMS group were less unwell at readmission is one such upstream
effect, rather than just a chance finding. However, in terms of
the outcomes that we believe policymakers, clinicians, and
patients and caregivers would find important, our tailored,
acceptable SMS technique was ineffectual.
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